The COVID-19 vaccine Pfizer produced with BioNTech is 100 per cent effective in children aged 12 to 15, according to a press release from the pharmaceutical giant.
As Eric Sorensen explains, while no shot has been approved for use for this age bracket yet, the preliminary results of the clinical trial are raising hopes for the future.